1. Home
  2. FENG vs ENLV Comparison

FENG vs ENLV Comparison

Compare FENG & ENLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Phoenix New Media Limited

FENG

Phoenix New Media Limited

HOLD

Current Price

$2.03

Market Cap

32.7M

Sector

Industrials

ML Signal

HOLD

Logo Enlivex Therapeutics Ltd.

ENLV

Enlivex Therapeutics Ltd.

HOLD

Current Price

$0.93

Market Cap

26.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FENG
ENLV
Founded
1998
2005
Country
China
Israel
Employees
N/A
N/A
Industry
Broadcasting
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
32.7M
26.6M
IPO Year
2011
1995

Fundamental Metrics

Financial Performance
Metric
FENG
ENLV
Price
$2.03
$0.93
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$7.00
AVG Volume (30 Days)
2.5K
11.5M
Earning Date
11-12-2025
11-28-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$106,947,410.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
9.17
N/A
52 Week Low
$1.28
$0.83
52 Week High
$3.65
$2.10

Technical Indicators

Market Signals
Indicator
FENG
ENLV
Relative Strength Index (RSI) 39.94 43.10
Support Level $2.01 $0.89
Resistance Level $2.08 $1.25
Average True Range (ATR) 0.04 0.16
MACD 0.01 -0.00
Stochastic Oscillator 13.33 5.26

Price Performance

Historical Comparison
FENG
ENLV

About FENG Phoenix New Media Limited

Phoenix New Media Ltd is a media company providing premium content on an integrated platform across the internet, mobile and TV channels in China. The company organizes its operations into two main segments: Net advertising services and Paid services. It provides its content and services through three channels: ifeng.com channel, video channel, and mobile channel. The company also offers a wide range of paid services including mobile value-added services, games, and content sales. It generates the majority of its revenue from Net advertising services. Geographically, it derives revenue from China.

About ENLV Enlivex Therapeutics Ltd.

Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and commercializing an allogeneic drug pipeline for rebalancing immune hyper-responses. The company's Allocetra is an immunotherapy that is being developed to rebalance a life-threatening unbalanced immune system, using the immune system's own natural regulation mechanisms.

Share on Social Networks: